Evidence map›Paper›PMID 33328572›Full record

ArticleCell death and differentiation2021

BCL(X)L and BCL2 increase the metabolic fitness of breast cancer cells: a single-cell imaging study.

Federico Lucantoni, Manuela Salvucci, Heiko Düssmann, Andreas U Lindner, Diether Lambrechts, Jochen H M Prehn

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Actionable Driver Events in Small Cell Lung Cancer.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Bcl-xL acts as an inhibitor of IPCell death and differentiation · 2022
    Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Federico LucantoniDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.ORCID http://orcid.org/0000-0001-5173-7836
Manuela SalvucciDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Heiko DüssmannDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.ORCID http://orcid.org/0000-0002-3582-8057
Andreas U LindnerDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Diether LambrechtsVIB Centre for Cancer Biology, Leuven, Belgium.ORCID http://orcid.org/0000-0002-3429-302X
Jochen H M PrehnDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland. jprehn@rcsi.ie.
Royal College of Surgeons in Ireland · IEVIB-KU Leuven Center for Cancer Biology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The BCL2 family of proteins regulate apoptosis by controlling mitochondrial outer membrane permeability. However, the effects on mitochondrial structure and bioenergetics have also been reported. Here we comprehensively characterized the effects of BCL2 and BCL(X)L on cellular energetics in MCF7 breast cancer cells using time-lapse confocal single-cell imaging and mitochondrial and cytosolic FRET reporters. We found that BCL2 and BCL(X)L increase the metabolic robustness of MCF7 cells, and that this was associated with increased mitochondrial NAD(P)H and ATP levels. Experiments with the F

Indexed as

bcl-X ProteinBreast NeoplasmsFemaleHumansSingle-Cell Analysisbcl-X Protein

Identifiers

PMID33328572
PMCPMC8166899
OpenAlexW3110648387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.